{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:04:12Z","timestamp":1792641852204,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.molmet.2024.101876","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T17:47:42Z","timestamp":1704908862000},"page":"101876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["NF1 deficiency drives metabolic reprogramming in ER+ breast cancer"],"prefix":"10.1016","volume":"80","author":[{"given":"Rachel (Rae) J.","family":"House","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Tovar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke N.","family":"Redlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curt J.","family":"Essenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Dischinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail E.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Beddows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Sheldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan C.","family":"Lien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie R.","family":"Graveel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Steensma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2024.101876_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41523-018-0080-8","article-title":"NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancer","volume":"4","author":"Dischinger","year":"2018","journal-title":"NPJ Breast Cancer"},{"issue":"7403","key":"10.1016\/j.molmet.2024.101876_bib2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11017","article-title":"The landscape of cancer genes and mutational processes in breast cancer","volume":"486","author":"Stephens","year":"2012","journal-title":"Nature"},{"issue":"7418","key":"10.1016\/j.molmet.2024.101876_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.molmet.2024.101876_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccell.2018.08.008","article-title":"The genomic landscape of endocrine-resistant advanced breast cancers","volume":"34","author":"Razavi","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.molmet.2024.101876_bib5","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1038\/s41467-018-05914-x","article-title":"The prognostic effects of somatic mutations in ER-positive breast cancer","volume":"9","author":"Griffith","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.molmet.2024.101876_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/annonc\/mdy497","article-title":"Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer","volume":"30","author":"Sokol","year":"2019","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.molmet.2024.101876_bib7","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1158\/1078-0432.CCR-18-4044","article-title":"Inactivating NF1 mutations are enriched in advanced breast cancer and contribute to endocrine therapy resistance","volume":"26","author":"Pearson","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.molmet.2024.101876_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1534\/genetics.112.142802","article-title":"Comparative oncogenomics implicates the neurofibromin 1 gene (NF1) as a breast cancer driver","volume":"192","author":"Wallace","year":"2012","journal-title":"Genetics"},{"issue":"7418","key":"10.1016\/j.molmet.2024.101876_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Cancer Genome Atlas","year":"2012","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.molmet.2024.101876_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrc3911","article-title":"A\u00a0RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor","volume":"15","author":"Ratner","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.molmet.2024.101876_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/bjc.2016.403","article-title":"Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors","volume":"116","author":"Uusitalo","year":"2017","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.molmet.2024.101876_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/gcc.22503","article-title":"Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer","volume":"57","author":"Wang","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"10.1016\/j.molmet.2024.101876_bib13","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/bjc.2015.78","article-title":"Age-specific risk of breast cancer in women with neurofibromatosis type 1","volume":"112","author":"Seminog","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.molmet.2024.101876_bib14","first-page":"531","article-title":"Increased risk of breast cancer in neurofibromatosis type 1: current insights","volume":"9","author":"Howell","year":"2017"},{"issue":"1","key":"10.1016\/j.molmet.2024.101876_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/bjc.2012.535","article-title":"Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study","volume":"108","author":"Seminog","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.molmet.2024.101876_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-4939-0888-2_9","article-title":"Oncogenic Ras pushes (and pulls) cell cycle progression through ERK activation","volume":"1170","author":"Campbell","year":"2014","journal-title":"Methods Mol Biol"},{"issue":"62","key":"10.1016\/j.molmet.2024.101876_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1023\/A:1006491619920","article-title":"Ras activation in human breast cancer","author":"von Lintig","year":"2000","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.molmet.2024.101876_bib18","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1172\/JCI119309","article-title":"Hyperexpression of mitogen-activated protein kinase in human breast cancer","volume":"99","author":"Sivaraman Vimala","year":"1997","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.molmet.2024.101876_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng0296-144","article-title":"Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells","volume":"12","author":"Bollag","year":"1996","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.molmet.2024.101876_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.molmet.2024.101876_bib21","first-page":"1","article-title":"Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies","volume":"11","author":"Phan","year":"2014","journal-title":"Cancer Biol Med"},{"issue":"4","key":"10.1016\/j.molmet.2024.101876_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncb3124","article-title":"Metabolic pathways promoting cancer cell survival and growth","volume":"17","author":"Boroughs","year":"2015","journal-title":"Nat Cell Biol"},{"issue":"5","key":"10.1016\/j.molmet.2024.101876_bib23","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.molmet.2024.101876_bib24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbabio.2018.05.003","article-title":"RAS signalling in energy metabolism and rare human diseases","volume":"1859","author":"Dard","year":"2018","journal-title":"Biochim Biophys Acta Bioenerg"},{"issue":"16","key":"10.1016\/j.molmet.2024.101876_bib25","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1128\/MCB.01868-08","article-title":"Mitochondrial dysfunction contributes to oncogene-induced senescence","volume":"29","author":"Moiseeva","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.molmet.2024.101876_bib26","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0006-291X(02)00391-1","article-title":"Activation of Ras cascade increases the mitochondrial enzyme content of respiratory competent yeast","volume":"293","author":"Laurent Dejean","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.molmet.2024.101876_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.canlet.2015.04.028","article-title":"Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K\/Akt signaling in human lung cancer cells","volume":"364","author":"Yao","year":"2015","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.molmet.2024.101876_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004715","article-title":"Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts","volume":"4","author":"Gaglio","year":"2009","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.molmet.2024.101876_bib29","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/onc.2014.207","article-title":"Blocking anaplerotic entry of glutamine into the TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs","volume":"34","author":"Saqcena","year":"2015","journal-title":"Oncogene"},{"issue":"7443","key":"10.1016\/j.molmet.2024.101876_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2024.101876_bib31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ebiom.2017.11.029","article-title":"Mice with an oncogenic HRAS mutation are resistant to high-fat diet-induced obesity and exhibit impaired hepatic energy homeostasis","volume":"27","author":"Oba","year":"2018","journal-title":"EBioMedicine"},{"issue":"7451","key":"10.1016\/j.molmet.2024.101876_bib32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature12138","article-title":"Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells","volume":"497","author":"Commisso","year":"2013","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.molmet.2024.101876_bib33","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1101\/gad.228122.113","article-title":"Exploiting the bad eating habits of Ras-driven cancers","volume":"27","author":"White","year":"2013","journal-title":"Genes Dev"},{"issue":"2","key":"10.1016\/j.molmet.2024.101876_bib34","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nm.4464","article-title":"Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models","volume":"24","author":"Schulte","year":"2018","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.molmet.2024.101876_bib35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.celrep.2016.12.056","article-title":"Absence of neurofibromin induces an oncogenic metabolic switch via mitochondrial ERK-mediated phosphorylation of the chaperone TRAP1","volume":"18","author":"Masgras","year":"2017","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.molmet.2024.101876_bib36","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/ng2004","article-title":"Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis-1 in Drosophila melanogaster","volume":"39","author":"Tong","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.molmet.2024.101876_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101224","article-title":"Loss of GTPase activating protein neurofibromin stimulates paracrine cell communication via macropinocytosis","volume":"27","author":"Ghoshal","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.molmet.2024.101876_bib38","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04940","article-title":"Neurofibromin controls macropinocytosis and phagocytosis in Dictyostelium","volume":"4","author":"Bloomfield","year":"2015","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.molmet.2024.101876_bib39","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/hmg\/ddt515","article-title":"NF1 is a critical regulator of muscle development and metabolism","volume":"23","author":"Sullivan","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.molmet.2024.101876_bib40","series-title":"Neurofibromin is essential to maintain metabolic function and sustain life in the adult mouse","author":"Turner","year":"2018"},{"issue":"55","key":"10.1016\/j.molmet.2024.101876_bib41","doi-asserted-by":"crossref","first-page":"94054","DOI":"10.18632\/oncotarget.21573","article-title":"Targeted inhibition of glutaminase as a potential new approach for the treatment of NF1 associated soft tissue malignancies","volume":"8","author":"Sheikh Tahir","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.molmet.2024.101876_bib42","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/cdd.2012.168","article-title":"Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model","volume":"20","author":"Sanchez-Macedo","year":"2013","journal-title":"Cell Death Differ"},{"issue":"6","key":"10.1016\/j.molmet.2024.101876_bib43","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.nut.2014.12.021","article-title":"Nutrient intake in neurofibromatosis type 1: a cross-sectional study","volume":"31","author":"de Souza","year":"2015","journal-title":"Nutrition"},{"issue":"7","key":"10.1016\/j.molmet.2024.101876_bib44","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/1346-8138.13218","article-title":"Nutritional, muscular and metabolic characteristics in patients with neurofibromatosis type 1","volume":"43","author":"Koga","year":"2016","journal-title":"J\u00a0Dermatol"},{"issue":"1","key":"10.1016\/j.molmet.2024.101876_bib45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.20945\/2359-3997000000007","article-title":"Increased insulin sensitivity in individuals with neurofibromatosis type 1","volume":"62","author":"Martins","year":"2018","journal-title":"Arch Endocrinol Metab"},{"issue":"22","key":"10.1016\/j.molmet.2024.101876_bib46","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3818","article-title":"Dissecting the rat mammary gland: isolation, characterization, and culture of purified mammary epithelial cells and fibroblasts","volume":"10","author":"Tovar","year":"2020","journal-title":"Bio Protoc"},{"issue":"1","key":"10.1016\/j.molmet.2024.101876_bib47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.molmet.2024.101876_bib48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"3","key":"10.1016\/j.molmet.2024.101876_bib49","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"issue":"17","key":"10.1016\/j.molmet.2024.101876_bib50","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.1074\/jbc.M116.774471","article-title":"Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements","volume":"292","author":"Mookerjee","year":"2017","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2024.101876_bib51","unstructured":"House, R., Eapen, J., Shen, H., Graveel, C., Steensma, M., CEAS: cellular energetics analysis software [Computer software]."},{"issue":"8","key":"10.1016\/j.molmet.2024.101876_bib52","doi-asserted-by":"crossref","DOI":"10.1139\/o59-099","article-title":"A\u00a0Rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can J Biochem Physiol"},{"issue":"3","key":"10.1016\/j.molmet.2024.101876_bib53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccell.2020.02.003","article-title":"Neurofibromin is an estrogen receptor-alpha transcriptional Co-repressor in breast cancer","volume":"37","author":"Zheng","year":"2020","journal-title":"Cancer Cell"},{"issue":"W1","key":"10.1016\/j.molmet.2024.101876_bib54","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"10.1016\/j.molmet.2024.101876_bib55","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4161\/cc.19800","article-title":"Oncogene-induced senescence results in marked metabolic and bioenergetic alterations","volume":"11","author":"Quijano","year":"2012","journal-title":"Cell Cycle"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877824000073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877824000073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T02:08:51Z","timestamp":1718935731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877824000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":55,"alternative-id":["S2212877824000073"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2024.101876","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NF1 deficiency drives metabolic reprogramming in ER+ breast cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2024.101876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101876"}}